Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Travel-Related Illness | 1 | 2017 | 1357 | 0.39 | Why? |
| Communicable Diseases, Imported | 1 | 2017 | 843 | 0.37 | Why? |
| Plasmids | 2 | 2018 | 840 | 0.28 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.27 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.26 | Why? |
| Chikungunya virus | 2 | 2016 | 339 | 0.23 | Why? |
| beta-Lactamases | 2 | 2018 | 759 | 0.23 | Why? |
| Klebsiella pneumoniae | 2 | 2017 | 658 | 0.22 | Why? |
| Chikungunya Fever | 2 | 2016 | 345 | 0.22 | Why? |
| Spondylarthropathies | 1 | 2020 | 163 | 0.20 | Why? |
| Kluyvera | 1 | 2018 | 5 | 0.20 | Why? |
| Blood Platelets | 2 | 2021 | 1704 | 0.19 | Why? |
| Fibromyalgia | 1 | 2021 | 174 | 0.19 | Why? |
| Azabicyclo Compounds | 1 | 2017 | 91 | 0.16 | Why? |
| Human papillomavirus 16 | 1 | 2017 | 95 | 0.16 | Why? |
| Neisseria gonorrhoeae | 1 | 2017 | 142 | 0.16 | Why? |
| Ceftazidime | 1 | 2017 | 134 | 0.15 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2018 | 214 | 0.15 | Why? |
| Osteoporosis | 1 | 2021 | 410 | 0.15 | Why? |
| Bacteriological Techniques | 1 | 2018 | 239 | 0.15 | Why? |
| Nails | 1 | 2017 | 143 | 0.14 | Why? |
| Scleroderma, Systemic | 1 | 2021 | 583 | 0.14 | Why? |
| Serogroup | 1 | 2017 | 510 | 0.14 | Why? |
| Nail Diseases | 1 | 2017 | 142 | 0.13 | Why? |
| Insect Vectors | 1 | 2016 | 227 | 0.13 | Why? |
| Latent Tuberculosis | 1 | 2018 | 324 | 0.13 | Why? |
| Hip Fractures | 1 | 2021 | 667 | 0.13 | Why? |
| Italy | 12 | 2021 | 38444 | 0.12 | Why? |
| Bacterial Proteins | 2 | 2018 | 1318 | 0.12 | Why? |
| Klebsiella Infections | 1 | 2017 | 466 | 0.12 | Why? |
| Aedes | 1 | 2016 | 380 | 0.12 | Why? |
| Streptococcus pneumoniae | 1 | 2017 | 827 | 0.11 | Why? |
| Pneumococcal Vaccines | 1 | 2017 | 571 | 0.11 | Why? |
| Pneumococcal Infections | 1 | 2017 | 562 | 0.10 | Why? |
| RNA, Viral | 1 | 2017 | 32276 | 0.10 | Why? |
| Immunity, Herd | 1 | 2017 | 1011 | 0.09 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.09 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.09 | Why? |
| Carcinoma, Squamous Cell | 1 | 2017 | 902 | 0.09 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.09 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.09 | Why? |
| Plasma | 1 | 2017 | 1809 | 0.08 | Why? |
| Arthritis, Rheumatoid | 1 | 2020 | 2043 | 0.08 | Why? |
| Anti-Bacterial Agents | 2 | 2017 | 10083 | 0.07 | Why? |
| Resilience, Psychological | 1 | 2020 | 2329 | 0.07 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.07 | Why? |
| Skin Neoplasms | 1 | 2017 | 1679 | 0.06 | Why? |
| Roseolovirus Infections | 1 | 2003 | 131 | 0.06 | Why? |
| Adaptation, Psychological | 1 | 2020 | 4996 | 0.06 | Why? |
| Social Media | 2 | 2020 | 5798 | 0.06 | Why? |
| Tuberculosis | 1 | 2018 | 2895 | 0.06 | Why? |
| Herpesvirus 6, Human | 1 | 2003 | 162 | 0.06 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.05 | Why? |
| Saliva | 1 | 2017 | 4679 | 0.05 | Why? |
| Platelet Function Tests | 1 | 2020 | 231 | 0.05 | Why? |
| Mitogens | 1 | 2018 | 8 | 0.05 | Why? |
| Microbial Sensitivity Tests | 2 | 2017 | 2886 | 0.05 | Why? |
| Prothrombin Time | 1 | 2020 | 434 | 0.04 | Why? |
| Imipenem | 1 | 2017 | 57 | 0.04 | Why? |
| Thienamycins | 1 | 2017 | 72 | 0.04 | Why? |
| Gentamicins | 1 | 2017 | 76 | 0.04 | Why? |
| Tuberculin Test | 1 | 2018 | 141 | 0.04 | Why? |
| Cell Adhesion Molecules | 1 | 2020 | 472 | 0.04 | Why? |
| Stress, Psychological | 1 | 2020 | 10231 | 0.04 | Why? |
| Minocycline | 1 | 2017 | 101 | 0.04 | Why? |
| beta-Lactamase Inhibitors | 1 | 2017 | 104 | 0.04 | Why? |
| Indian Ocean | 1 | 2016 | 29 | 0.04 | Why? |
| Depression | 1 | 2020 | 14116 | 0.04 | Why? |
| Young Adult | 5 | 2017 | 93724 | 0.04 | Why? |
| Humans | 21 | 2021 | 930598 | 0.04 | Why? |
| Benin | 1 | 2015 | 115 | 0.04 | Why? |
| Interferon-gamma Release Tests | 1 | 2018 | 253 | 0.04 | Why? |
| beta-Lactams | 1 | 2017 | 210 | 0.04 | Why? |
| Cephalosporins | 1 | 2017 | 250 | 0.04 | Why? |
| Rectum | 1 | 2018 | 495 | 0.04 | Why? |
| Genome, Bacterial | 1 | 2018 | 446 | 0.04 | Why? |
| Antigens, Bacterial | 1 | 2018 | 330 | 0.04 | Why? |
| Privacy | 1 | 2020 | 636 | 0.03 | Why? |
| Anxiety | 1 | 2020 | 17311 | 0.03 | Why? |
| Adolescent | 4 | 2018 | 86841 | 0.03 | Why? |
| Seizures | 1 | 2003 | 1163 | 0.03 | Why? |
| Arthritis, Psoriatic | 1 | 2020 | 625 | 0.03 | Why? |
| Technology | 1 | 2020 | 812 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Platelet Count | 1 | 2020 | 1381 | 0.03 | Why? |
| Female | 10 | 2021 | 380317 | 0.03 | Why? |
| Enterobacteriaceae Infections | 1 | 2018 | 529 | 0.03 | Why? |
| Drug Interactions | 1 | 2020 | 1653 | 0.03 | Why? |
| Male | 9 | 2021 | 367725 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Adult | 7 | 2020 | 244371 | 0.03 | Why? |
| Phylogeography | 1 | 2016 | 824 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Disseminated Intravascular Coagulation | 1 | 2020 | 994 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 2 | 2015 | 11559 | 0.03 | Why? |
| Base Sequence | 1 | 2018 | 3581 | 0.03 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.02 | Why? |
| Endothelial Cells | 1 | 2020 | 2048 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Aged | 4 | 2020 | 215776 | 0.02 | Why? |
| Endothelium, Vascular | 1 | 2020 | 1751 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.02 | Why? |
| Drug Combinations | 1 | 2017 | 3852 | 0.02 | Why? |
| Middle Aged | 4 | 2020 | 270681 | 0.02 | Why? |
| Africa | 1 | 2016 | 2986 | 0.02 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2003 | 5164 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Venous Thrombosis | 1 | 2020 | 2739 | 0.02 | Why? |
| Urban Population | 1 | 2015 | 2000 | 0.02 | Why? |
| Nervous System Diseases | 1 | 2003 | 4092 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Genotype | 1 | 2016 | 4697 | 0.02 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.02 | Why? |
| Internet | 1 | 2021 | 6204 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2015 | 51949 | 0.01 | Why? |
| Evolution, Molecular | 1 | 2016 | 3691 | 0.01 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 7868 | 0.01 | Why? |
| Infant | 2 | 2018 | 30274 | 0.01 | Why? |
| France | 1 | 2016 | 12074 | 0.01 | Why? |
| Seroepidemiologic Studies | 1 | 2015 | 10017 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.01 | Why? |
| Pregnancy | 2 | 2015 | 23879 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Mutation | 1 | 2016 | 12376 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| DNA, Viral | 1 | 2003 | 2521 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2003 | 6740 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2016 | 27595 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.00 | Why? |
| Animals | 1 | 2016 | 78931 | 0.00 | Why? |
Landini's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(150)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(77)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_